Aqua Bio Technology ASA: Disclosure of large shareholdings

Reference is made to the stock exchange notice from Aqua Bio Technology ASA ("ABTEC" or the "Company") published on 13 March 2026 regarding the Extraordinary General Meeting approving a NOK 50 million debt conversion with the issuance of 10,000,000 new shares (the "New Shares") in the Company, at a subscription price of NOK 5.00 per New Share (the "Debt Conversion").

The following shareholders of the Company have, on 14 March 2026, been allocated New Shares in the Debt Conversion which implies that their holdings have surpassed a notifiable threshold:

· Forza NO AS has been allocated 2,716,216 New Shares in the Debt Conversion. Following this and upon completion of the Debt Conversion, Forza NO AS will hold 3,096,473 shares in the Company, corresponding to 20.3% of the shares and votes in the Company; and · Terabyte Holding AS, a company controlled by ABTEC board member Terje Blytt, has been allocated 2,310,811 New Shares in the Debt Conversion. Following this and upon completion of the Debt Conversion, Terabyte Holding AS will hold 2,638,211 shares in the Company, corresponding to 17.3% of the shares and votes in the Company; and · Expo Holding AS, a company controlled by Martin Siem, has been allocated 1,891,892 New Shares in the Debt Conversion. Following this and upon completion of the Debt Conversion, Martin Siem and associated companies will hold 2,253,187 shares in the Company, corresponding to 14.8% of the shares and votes in the Company; and · Norlane AS, a company controlled by ABTEC chairman Roger Sedal, has been allocated 1,662,162 New Shares in the Debt Conversion. Following this and upon completion of the Debt Conversion, Norlane AS will hold 1,828,368 shares in the Company, corresponding to 12.0% of the shares and votes in the Company; and · Dank I Halden AS has been allocated 1,418,919 New Shares in the Debt Conversion. Following this and upon completion of the Debt Conversion, Dank I Halden AS will hold 1,617,572 shares in the Company, corresponding to 10.6% of the shares and votes in the Company. The following shareholders have had their holdings diluted as a consequence of the Debt Conversion, and thereby surpassed a notifiable threshold:

· Following completion of the Debt Conversion, RH Industri AS and Roger Hofseth will hold 464,355 shares in the Company, corresponding to 3.0% of the shares and votes in the Company; and · Following completion of the Debt Conversion, Intelco AS and Øystein Tvenge will hold 419,491 shares in the Company, corresponding to 2.8% of the shares and votes in the Company; and · Following completion of the Debt Conversion, PJUR Eiendom AS will hold 418,269 shares in the Company, corresponding to 2.7% of the shares and votes in the Company. The calculations in this notice are based on a total number of shares in the Company of 15,227,935 following completion of the Debt Conversion, and registration of the shares in the Norwegian Register of Business Enterprises. This disclosure is made pursuant to section 4-2 of the Norwegian Securities Trading Act.

Contacts Kristian Flaten CEO & CFO Aqua Bio Technology ASA

Phone: +47 9509 2322 Email: kf@aquabiotech.no

About Us Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in skincare and nonfood. The group has distribution towards B2C and B2B, and offers freight, customs, and logistics services. The group also develops sustainable biotechnology for use in skincare products. Aqua Bio Technology is listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-03-16 07:30 CET.